Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SALINE-FILLED BREAST IMPLANT CONTINUED AVAILABILITY

This article was originally published in The Gray Sheet

Executive Summary

SALINE-FILLED BREAST IMPLANT CONTINUED AVAILABILITY pending completion of ongoing research will be urged by the American Society for Aesthetic Plastic Surgery at a June 2 public hearing on the devices. "Given the current status of ongoing research into the safety and efficacy of silicone inflatable [saline filled] breast implants, FDA should allow additional time for the results of this research to be completed and evaluated prior to the agency issuing a final rule to require the filing of a [premarket approval application] for the device," the group says in a request to appear at the hearing.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002373

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel